Net Income

Inside the TIGER 21 summit where the world’s ultra-rich strategize on AI, global instability, and the $83 trillion wealth transfer.

With the AI services market heating up, Bitwise appoints Sarith Sabarinath to sharpen its narrative and drive global growth. Here's why the move is critical.

The Canadian broker's 2025 report reveals a massive jump in donations and over 3,400 employee volunteer hours, targeting key areas of societal risk.

For the first time, NCH's heart institute earns national recognition, driven by AI-powered tech and a commitment to world-class care in Southwest Florida.

The nation's top IV therapy franchise reports record growth, but its expansion highlights a booming wellness industry navigating a complex regulatory landscape.

A new pilot program uses AI to find hidden patterns in past cancer trial data, aiming to get the right drugs to the right patients, faster.

Top execs from finance and tech join Relay Resources' board, bringing corporate power to accelerate its disability inclusion and social enterprise goals.

With strong revenue, key AI upgrades, and a top Microsoft award, Blue Yonder is solidifying its market lead as global supply chain pressures intensify.

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.

Amid market volatility, Lavior is boosting US production and launching dual product lines, a strategic move to ensure stability for clinics and consumers alike.

A new 'zero-disruption' plate from TheWell Bioscience aims to solve key challenges in organoid research, promising more reliable data for drug discovery.

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

Safe Harbor Financial secures a landmark deal with PCCU, boosting revenue by $9M but taking on more risk. A bold move in the evolving cannabis finance world.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

Universal Corporation appoints Steven Diel, the mind behind its ingredients push, as CFO, signaling a firm commitment to diversification despite headwinds.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

A landmark deal will see Takeda use Iambic's AI platform to slash drug development timelines and fast-track new medicines for cancer and other diseases.

Guardforce AI aims to acquire a leading speech therapy platform, signaling a major strategic pivot from secured logistics to the booming AI healthcare market.

After a year-long restructuring, SVCV launches asset manager NextRock to acquire 100 companies and build a cross-industry empire from finance to fashion.